Intervention Mediators in a Randomized Controlled Trial to Increase Colonoscopy Uptake Among Individuals at Increased Risk of Familial Colorectal Cancer

Abstract

ClinicalTrials.gov , NCT01274143.

Saúde digital e telemedicina aplicados ao câncer colorretal: uma revisão

“…Fonte: os autores (2020) Nos estudos que abordavam o assunto triagem, portanto, dois utilizaram aplicativo e/ou programas eletrônicos (MEHTA et al, 2018;MILLER et al, 2018), um fez uso de carta e telefonema (STEFFEN et al, 2015); um fez uso de carta e programa eletrônico (CONORADO et al, 2018); um fez uso de mensagens de texto (HAGOEL et al, 2016); e um, de telefonema (BRUMBACH et al, 2017). Dentre os seis artigos, cinco relataram eficácia em seus programas (STEFFEN et al, 2015;HAGOEL et al, 2016;BRUMBACH et al, 2017;MILLER et al, 2018;CONORADO et al, 2018), contudo, em dois deles, a eficácia apresentada foi moderada (HAGOEL et al, 2016;BRUMBACH et al, 2017). Por outro lado, um dos estudos não demonstrou eficácia em sua intervenção (MEHTA et al, 2018).…”

“…Por outro lado, um dos estudos não demonstrou eficácia em sua intervenção (MEHTA et al, 2018). Apenas um trabalho fez uso da telemedicina para apoio ao atendimento desses pacientes (BRUMBACH et al, 2017).…”

Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial

“…Provider knowledge about hereditary cancer risk and recommending CGRA to patients can be powerful predictors of guideline concordant care. [34, 77] Yet knowledge about cancer genetics is limited among healthcare providers,[78, 79] [80]which may help explain widespread deficiency in the identification of individuals and risk-appropriate care for women at high risk for HBOC. [81] Despite limited knowledge and time constraints, healthcare providers are generally receptive to educational opportunities.…”

How to Ensure Patient Adherence to Colorectal Cancer Screening and Surveillance in Your Practice

“…15,42,45,[50][51][52][53] This approach is also suitable for surveillance in high-risk patients, that is, noncompliance with post-FIT-positive colonoscopy or with a positive family history. 23,[54][55][56][57] In this regard, the endoscopist is expected to merge the endoscopic and pathologic information to provide recommendations regarding appropriate postpolypectomy surveillance intervals. The involvement of primary providers at this stage may also be beneficial, but data are conflicting.…”